Showing results (71-80 of 187) with videos related to

Sort By:
Pageof 19
Cancer Chemotherapy and Pharmacology|March 19, 2011
Phase II study of FOLFOX4 with "wait and go" strategy as first-line treatment for metastatic colorectal cancerMitsugu Kochi, Wataru Ichikawa, Eiji Meguro, et al.
Bioorganic & Medicinal Chemistry|July 25, 2012
Fused bicyclic heteroarylpiperazine-substituted L-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile groupTomohiro Yoshida, Fumihiko Akahoshi, Hiroshi Sakashita, et al.
Cancer|March 26, 2011
Steroid receptor expression in thymomas and thymic carcinomasTakahiro Mimae, Koji Tsuta, Fumiaki Takahashi, et al.
Cureus|December 3, 2025
Correlation Between Intratumoral NETs and Neutrophil-to-Lymphocyte Ratio in Gastric CancerMasahiro Takeuchi, Chise Shiraishi, Yurika Fukudome, et al.
International Journal of Biochemistry and Molecular Biology|July 10, 2012
Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoterQiuying Cheng, Xiang Ling, Andrew Haller, et al.
Breast Cancer Research and Treatment|April 5, 2013
Impact of recent parity on histopathological tumor features and breast cancer outcome in premenopausal Japanese womenAkiko Kawano Nagatsuma, Chikako Shimizu, Fumiaki Takahashi, et al.
JAMA Oncology|October 5, 2017
Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard RatioKyongsun Pak, Hajime Uno, Dae Hyun Kim, et al.
International Journal of Hematology|September 29, 2017
Ruxolitinib is effective and safe in Japanese patients with hydroxyurea-resistant or hydroxyurea-intolerant polycythemia vera with splenomegalyKeita Kirito, Kenshi Suzuki, Koichi Miyamura, et al.
Breast Cancer Research and Treatment|March 9, 2005
Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancerKan Yonemori, Noriyuki Katsumata, Hajime Uno, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 19, 2008
The short treatment with the angiotensin receptor blocker candesartan surveyed by telemedicine (STAR CAST) study: rationale and study designHiroyuki Sasamura, Hideaki Nakaya, Stevo Julius, et al.
Pageof 19